GEORGE WILDING, MD
Osteopathic Medicine at Highland Ave, Madison, WI
License number
Wisconsin 29064
Category
Osteopathic Medicine
Type
Medical Oncology
Address
Address
600 Highland Ave, Madison, WI 53792
Phone
(608) 265-1700
(608) 262-1982 (Fax)
(608) 262-1982 (Fax)
Organization information
See more information about GEORGE WILDING at bizstanding.comGeorge Wilding
3608 Richie Rd, Madison, WI 53593
Industry:
Educational Services
George Wilding MD
600 Highland Ave, Madison, WI 53792
Industry:
Oncology, Internist
Phone:
(608) 265-1700 (Phone)
George T. Wilding
Professional information
Dr. George Wilding, Madison WI - MD (Doctor of Medicine)
Specialties:
Oncology, Medical Oncology
Address:
600 Highland Ave STE K4, Madison 53792
(608) 265-1700 (Phone), (608) 833-6932 (Fax)
1111 Highland Ave, Madison 53705
(608) 263-8610 (Phone)
UNIVERSITY OF WISCONSIN HOSPITAL AND CLINICS
600 Highland Ave, Madison 53792
(608) 263-6400 (Phone), (608) 829-5315 (Fax)
Carbone Cmprhnsv Cancer Center
600 Highland Ave, Madison 53792
(608) 265-1700 (Phone)
(608) 265-1700 (Phone), (608) 833-6932 (Fax)
1111 Highland Ave, Madison 53705
(608) 263-8610 (Phone)
UNIVERSITY OF WISCONSIN HOSPITAL AND CLINICS
600 Highland Ave, Madison 53792
(608) 263-6400 (Phone), (608) 829-5315 (Fax)
Carbone Cmprhnsv Cancer Center
600 Highland Ave, Madison 53792
(608) 265-1700 (Phone)
Certifications:
Internal Medicine, 1983, Medical Oncology, 1985
Awards:
Healthgrades Honor Roll
Languages:
English
Hospitals:
600 Highland Ave STE K4, Madison 53792
1111 Highland Ave, Madison 53705
UNIVERSITY OF WISCONSIN HOSPITAL AND CLINICS
600 Highland Ave, Madison 53792
Carbone Cmprhnsv Cancer Center
600 Highland Ave, Madison 53792
Hospital of the University of Pennsylvania
3400 Spruce St, Philadelphia 19104
Memorial Sloan - Kettering Cancer Center
1275 York Ave, New York 10065
Richland Hospital
333 East 2 St, Richland Center 53581
University of Wisconsin Hospitals And Clinics
600 Highland Ave, Madison 53792
1111 Highland Ave, Madison 53705
UNIVERSITY OF WISCONSIN HOSPITAL AND CLINICS
600 Highland Ave, Madison 53792
Carbone Cmprhnsv Cancer Center
600 Highland Ave, Madison 53792
Hospital of the University of Pennsylvania
3400 Spruce St, Philadelphia 19104
Memorial Sloan - Kettering Cancer Center
1275 York Ave, New York 10065
Richland Hospital
333 East 2 St, Richland Center 53581
University of Wisconsin Hospitals And Clinics
600 Highland Ave, Madison 53792
Education:
Medical School
University Of Massachusetts Medical School
Graduated: 1980
Clinical Center At The Nih
University Ma Mem Hlthcare University Campus
University Of Massachusetts Medical School
Graduated: 1980
Clinical Center At The Nih
University Ma Mem Hlthcare University Campus
N1,N4-Bis(Buta-1,3-Dienyl)Butane-1,4-Diamine Pharmaceutical Compositions And Methods Thereof
US Patent:
2008011, May 15, 2008
Filed:
May 3, 2007
Appl. No.:
11/800173
Inventors:
Hirak S. Basu - Madison WI, US
Dawn R. Church - Stoughton WI, US
Patrick M. Woster - Canton MI, US
George Wilding - Verona WI, US
Dawn R. Church - Stoughton WI, US
Patrick M. Woster - Canton MI, US
George Wilding - Verona WI, US
International Classification:
A61K 31/13
US Classification:
514673
Abstract:
N1,N4-bis(buta-1,3-dienyl)butane-1,4-diamine dihydrochloride (also referred to as MDL 72,527 and N,N′-di-2,3-butadienyl-1,4-butanediamine dihydrochloride), or salts or solvates thereof, its use as an antioxidant, its use in preventing and/or treating prostate cancer in male humans, and its use in reducing the concentration of reactive oxygen species in human prostate gland tissue or any other body tissue, and methods of making the compound thereof. Other methods include inhibiting acetyl polyamine oxidase in human prostate tissue or other human body tissue comprising administering a therapeutic amount of N,N′-bis(2,3-butadienyl)-1,4-butanediamine or a salt or solvate thereof to the human, and a method of determining oxidative stress in human prostate tissue or other human or animal body tissue comprising measuring a ratio of oxidized 2′,7′-dichlorodihydrofluorescein diacetate fluorescence:DNA fluorescence and hydroethidine dye fluorescence ex vivo or in vivo.
Chroman-Derived Anti-Androgens For Treatment Of Androgen Mediated Disorders
US Patent:
2014004, Feb 13, 2014
Filed:
Aug 14, 2013
Appl. No.:
13/966775
Inventors:
George Wilding - Verona WI, US
Assignee:
Wisconsin Alumni Research Corporation - Madison WI
International Classification:
A61K 31/353
US Classification:
514456
Abstract:
Methods for the prevention and/or alleviation of androgen-mediated disorders treatable by administering a chroman-derived anti-androgen compound are provided by the present invention. The invention further provides pharmaceutical and nutraceutical compositions containing chroman-derived anti-androgen compounds useful in the prevention and/or alleviation of androgen-mediated disorders, particularly prostate cancer.
Chroman-Derived Anti-Androgens For Treatment Of Androgen-Mediated Disorders
US Patent:
2010005, Mar 4, 2010
Filed:
Oct 19, 2009
Appl. No.:
12/581501
Inventors:
Todd A. Thompson - Madison WI, US
George Wilding - Verona WI, US
George Wilding - Verona WI, US
International Classification:
A61K 31/352, C12N 5/02
US Classification:
514456, 435375
Abstract:
Methods for the prevention and/or alleviation of androgen-mediated disorders by administering a chroman-derived anti-androgen compound are provided by the present invention. The invention further provides pharmaceutical and nutraceutical compositions containing chroman-derived anti-androgen compounds useful in the prevention and/or alleviation of androgen-mediated disorders, particularly prostate cancer.
Chroman-Derived Anti-Androgens For Treatment Of Androgen-Mediated Disorders
US Patent:
2005019, Sep 1, 2005
Filed:
Feb 27, 2004
Appl. No.:
10/789835
Inventors:
Todd Thompson - Madison WI, US
George Wilding - Verona WI, US
George Wilding - Verona WI, US
International Classification:
A61K031/353
US Classification:
514456000
Abstract:
Methods for the prevention and/or alleviation of androgen-mediated disorders treatable by administering a chroman-derived anti-androgen compound are provided by the present invention. The invention further provides pharmaceutical and nutraceutical compositions containing chroman-derived anti-androgen compounds useful in the prevention and/or alleviation of androgen-mediated disorders, particularly prostate cancer.
Chroman-Derived Anti-Androgens For Treatment Of Androgen Mediated Disorders
US Patent:
8536219, Sep 17, 2013
Filed:
Jul 5, 2012
Appl. No.:
13/542432
Inventors:
Todd A. Thompson - Madison WI, US
George Wilding - Verona WI, US
George Wilding - Verona WI, US
Assignee:
Wisconsin Alumni Research Foundation - Madison WI
International Classification:
A61K 31/353
US Classification:
514456
Abstract:
Methods for the prevention and/or alleviation of androgen-mediated disorders treatable by administering a chroman-derived anti-androgen compound are provided by the present invention. The invention further provides pharmaceutical and nutraceutical compositions containing chroman-derived anti-androgen compounds useful in the prevention and/or alleviation of androgen-mediated disorders, particularly prostate cancer.
Chroman-Derived Compounds For The Treatment Of Cancer
US Patent:
7863324, Jan 4, 2011
Filed:
May 29, 2008
Appl. No.:
12/129338
Inventors:
Todd A. Thompson - Madison WI, US
George Wilding - Verona WI, US
George Wilding - Verona WI, US
Assignee:
Wisconsin Alumni Research Foundation - Madison WI
International Classification:
A61K 31/353
US Classification:
514456, 514458
Abstract:
The present invention provides methods for inhibiting the growth of androgen-independent prostate cancer tumor cells in a human comprising administering to the human. The invention further provides pharmaceutical and nutraceutical compositions containing chroman-derived compounds useful in the alleviation of cancer.
Androgen Induced Oxidative Stress Inhibitors
US Patent:
2013021, Aug 15, 2013
Filed:
Apr 15, 2011
Appl. No.:
13/641662
Inventors:
Hirak S. Basu - Madison WI, US
David A. Zarling - Menlo Park CA, US
George Wilding - Verona WI, US
Dawn R. Church - Stoughton WI, US
David A. Zarling - Menlo Park CA, US
George Wilding - Verona WI, US
Dawn R. Church - Stoughton WI, US
Assignee:
COLBY PHARMACEUTICAL COMPANY - Menlo Park CA
International Classification:
C07D 311/42, C07D 405/12
US Classification:
514150, 534780, 549286, 514456, 5462831, 514337
Abstract:
Described herein are pharmaceutical compositions and medicaments, and methods of using such pharmaceutical compositions and medicaments in the treatment of cancer.